{"id":"alcaftadine-ophthalmic-solution-0-25","safety":{"commonSideEffects":[{"rate":"10%","effect":"Eye irritation"},{"rate":"5%","effect":"Headache"},{"rate":"5%","effect":"Dry mouth"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Alcaftadine is an antihistamine that selectively inhibits the histamine H1 receptor.","oneSentence":"Antihistamine","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:21:32.725Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic conjunctivitis"}]},"trialDetails":[{"nctId":"NCT02555761","phase":"","title":"Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea","status":"COMPLETED","sponsor":"Allergan","startDate":"2015-10-19","conditions":"Conjunctivitis, Allergic","enrollment":3423},{"nctId":"NCT00889330","phase":"PHASE3","title":"Safety and Efficacy Study of a Eye Drop for Eye Allergy","status":"COMPLETED","sponsor":"Vistakon Pharmaceuticals","startDate":"2009-04","conditions":"Allergic Conjunctivitis","enrollment":60},{"nctId":"NCT01732757","phase":"PHASE4","title":"A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Allergan","startDate":"2012-11","conditions":"Conjunctivitis, Allergic","enrollment":157},{"nctId":"NCT01470118","phase":"PHASE4","title":"A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-10","conditions":"Conjunctivitis, Allergic","enrollment":127}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lastacaft®"],"phase":"phase_2","status":"active","brandName":"Alcaftadine Ophthalmic Solution 0.25%","genericName":"Alcaftadine Ophthalmic Solution 0.25%","companyName":"Allergan","companyId":"allergan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antihistamine Used for Allergic conjunctivitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}